These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36414698)
41. Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML. Rashidi A; Slade M; DiPersio JF; Westervelt P; Vij R; Romee R Bone Marrow Transplant; 2016 Dec; 51(12):1561-1564. PubMed ID: 27526282 [TBL] [Abstract][Full Text] [Related]
42. Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation. El-Cheikh J; Devillier R; Dulery R; Massoud R; Al Chami F; Ghaoui N; Moukalled N; Pagliardini T; Marino F; Malard F; Bazarbachi AH; Mohty R; Bazarbachi A; Castagna L; Mohty M; Blaise D Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):617-623. PubMed ID: 32457025 [TBL] [Abstract][Full Text] [Related]
43. Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas. Montes de Oca C; Castagna L; De Philippis C; Bramanti S; Schiano JM; Pagliardini T; Collignon A; Harbi S; Mariotti J; Granata A; Maisano V; Furst S; Legrand F; Chabannon C; Carlo-Stella C; Santoro A; Blaise D; Devillier R Biol Blood Marrow Transplant; 2020 Dec; 26(12):2299-2305. PubMed ID: 32822845 [TBL] [Abstract][Full Text] [Related]
44. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557 [TBL] [Abstract][Full Text] [Related]
45. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. Ruggeri A; Sun Y; Labopin M; Bacigalupo A; Lorentino F; Arcese W; Santarone S; Gülbas Z; Blaise D; Messina G; Ghavamzadeh A; Malard F; Bruno B; Diez-Martin JL; Koc Y; Ciceri F; Mohty M; Nagler A Haematologica; 2017 Feb; 102(2):401-410. PubMed ID: 27758821 [TBL] [Abstract][Full Text] [Related]
46. Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma. Mariotti J; Devillier R; Bramanti S; Giordano L; Sarina B; Furst S; Granata A; Maisano V; Pagliardini T; De Philippis C; Kogan M; Faucher C; Harbi S; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L Biol Blood Marrow Transplant; 2019 Sep; 25(9):1810-1817. PubMed ID: 31128326 [TBL] [Abstract][Full Text] [Related]
47. Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation. Harada K; Najima Y; Kato M; Fuji S; Shinohara A; Nakamae H; Toyosaki M; Ashiarai M; Onizuka M; Hashii Y; Ichinohe T; Atsuta Y; Nakasone H Int J Hematol; 2022 Nov; 116(5):744-753. PubMed ID: 35767142 [TBL] [Abstract][Full Text] [Related]
48. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis. Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785 [TBL] [Abstract][Full Text] [Related]
49. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia. Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F Front Immunol; 2020; 11():699. PubMed ID: 32477328 [TBL] [Abstract][Full Text] [Related]
50. Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Nagler A; Labopin M; Koc Y; Angelucci E; Tischer J; Arat M; Pioltelli P; Bernasconi P; Chiusolo P; Diez-Martin JL; Sanz J; Ciceri F; Peric Z; Giebel S; Canaani J; Mohty M Cancer; 2021 Jul; 127(14):2507-2514. PubMed ID: 33739471 [TBL] [Abstract][Full Text] [Related]
51. Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Ruggeri A; Galimard JE; Labopin M; Rafii H; Blaise D; Ciceri F; Diez-Martin JL; Cornelissen J; Chevallier P; Sanchez-Guijo F; Nicholson E; Castagna L; Forcade E; Kuball J; Rovira M; Koc Y; Pavlu J; Gulbas Z; Vydra J; Baron F; Sanz J; Spyridonidis A; Savani B; Gluckman E; Nagler A; Mohty M Transplant Cell Ther; 2022 Oct; 28(10):710.e1-710.e10. PubMed ID: 35830930 [TBL] [Abstract][Full Text] [Related]
52. Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC. Bailén R; Pascual-Cascón MJ; Guerreiro M; López-Corral L; Chinea A; Bermúdez A; Sampol A; Heras I; García-Torres E; Torres M; Roca JR; Herruzo B; Sanz J; Fonseca M; Herrera P; Colorado M; Bento L; López-Godino O; Martín-Calvo C; Fernández-Caldas P; Marcos-Jubilar M; Sánchez-Ortega I; Solano C; Noriega V; Humala K; Oarbeascoa G; Díez-Martín JL; Kwon M; Transplant Cell Ther; 2022 Apr; 28(4):204.e1-204.e10. PubMed ID: 35108627 [TBL] [Abstract][Full Text] [Related]
53. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML. Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415 [TBL] [Abstract][Full Text] [Related]
54. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668 [TBL] [Abstract][Full Text] [Related]
56. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide. Shimoni A; Labopin M; Lorentino F; Van Lint MT; Koc Y; Gülbas Z; Tischer J; Bruno B; Blaise D; Pioltelli P; Afanasyev B; Ciceri F; Mohty M; Nagler A Leukemia; 2019 Jan; 33(1):230-239. PubMed ID: 29907809 [TBL] [Abstract][Full Text] [Related]
57. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome. Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919 [TBL] [Abstract][Full Text] [Related]
58. FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Rodríguez-Arbolí E; Labopin M; Tischer J; Brecht A; Ganser A; Finke J; Blau IW; Kröger N; Kalhs P; Forcade E; Bunjes D; Spyridonidis A; Savani B; Nagler A; Mohty M Biol Blood Marrow Transplant; 2020 Nov; 26(11):2165-2173. PubMed ID: 32717436 [TBL] [Abstract][Full Text] [Related]
59. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies. Katsanis E; Sapp LN; Varner N; Koza S; Stea B; Zeng Y Biol Blood Marrow Transplant; 2018 Oct; 24(10):2034-2039. PubMed ID: 29908231 [TBL] [Abstract][Full Text] [Related]
60. Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation. Muñiz P; Andrés-Zayas C; Carbonell D; Chicano M; Bailén R; Oarbeascoa G; Suárez-González J; Gómez Centurión I; Dorado N; Gallardo D; Anguita J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I Front Immunol; 2022; 13():1002959. PubMed ID: 36211438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]